drugset / Trial / NCT00513279
To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334
RandomizedCrossoverTreatment
Summary
GSK618334 is being developed as an innovative treatment for substance dependence and potentially other compulsive behavioral disorders. This study will evaluate the safety, tolerability and pharmacokinetics of single doses of GSK618334 in healthy volunteers.
Timeline
- Start
- 2007-06-28
- Primary completion
- 2007-10-04
- Completion
- 2007-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK618334 | Unknown | 2.5 mg | Oral |
| Subject | GSK618334 | Unknown | 25 mg | Oral |
| Subject | GSK618334 | Unknown | 100 mg | Oral |
| Subject | GSK618334 | Unknown | 400 mg | Oral |